EFNA welcomes the #eupharma strategy revision, focusing on the patient-centered approach & its potential to enhance treatments for neuro conditions. We highlight some issues specific to neuro patients in our #eupharma statement: ow.ly/K2a550OKin8

vem ai um mingau de aveia passivona??

#BlankTheSeries #FayeYoko

Activating change this week, PAREA unveiled a policy paper challenging norms on mental health needs. As the EU revises the pharma package, we advocate for a recalibration, aligning medicine development with public health priorities. Read more: bit.ly/3SEGOdj #EUpharma

Pull incentives can #BridgeTheGap in health innovations and save countless lives. ⬇️

The #EUPharma legislation is a golden opportunity to promote pull incentives to tackle infectious diseases such as #TB & #malaria . We count on the EU to not leave millions of people behind.

📢 We welcome the European Parliament reports on the revision of the #EUPharma Legislation and provide recommendations for future negotiations to guarantee accessibility and effectiveness of medicines for patients

👉 Press release: cpme.eu/news/good-but-…

#EUPharma Strategy #EPlenary

Starting #EUpharma day with a debate on #medicineshortages . Will the proposal help to address the problem by putting forward proactive solutions tackling some of the major root causes to #FightShortages4Patients ? Let’s wait and see!

Attending the #EANM23 Congress on #NuclearMedicine where the Revision of the #EUPharma Legislation is catching everyone eyes. 💊☢️👀

The #EUpharma package is a real opportunity to tackle the twin problems of medicine shortages & high prices. The EU Parliament has just voted through improvements to it, although without going the full mile for consumers.
#AccessToMedicines
➡️beuc.eu/press-releases…

Day 2 of ACE Conference in Athens kicks off with 'Business Outlook - EU Pharma Briefing'. Examining the European Pharma sector's outlook, through data-driven discussions and expert insights, navigating challenges and seeking opportunities.

#ACEAthens23 #EUPharma #AmChamGR

At the 🇧🇪Presidency #EU2024BE event this morning to discuss needs-driven healthcare, Ancel·la Santos will argue we need new medicines at affordable prices. The #EUpharma package must help bring down prices or risk putting health spending at national level in an impossible situation.

READ | Seizing the opportunity for European leadership on #AntibioticDevelopment and access💊

'Improved regulatory pathways for product development are needed, particularly to build trust and encourage alignment of stakeholders.'

🖹 frnds.eu/AMREuropeanLea…

#EUPharma #AMR

The #EUPharma reform will ensure that the 🇪🇺 continues to have one of the most generous incentives systems in the world - but better targeted to our citizens’ needs.
Read our🆕factsheet to find out more ⤵️
europa.eu/!wVKCfm
#HealthUnion

95% of #Rarediseases currently have no treatment option. This must change! Read our🆕factsheet to find out how the #EUPharma reform addresses unmet medical needs⤵️
europa.eu/!PDkj8X #HealthUnion

It is vital that the upcoming revision of the EU pharmaceutical legislation includes practical policies and incentives to strengthen the European medicines industry. As a pioneer in sustainable antibiotic API production, Centrient is ready to share our expertise.

#EUPharma

Today PGEU organized its monthly Advisory Working Group in which topics such as Pharmaceutical Legislation and European Health Data Space were thoroughly discussed by our members.
#EUPharma #health #EHDS #phamacists

We’re working to enhance security of supply, so that medicines are available for all 🇪🇺 citizens at all times.
Read our 🆕factsheet to find out how the #EUPharma reform will deliver this⤵️
europa.eu/!qpqn9x
#HealthUnion

Missed the latest #MEPsAgainstCancer webinar? Watch the recording of the discussion on the revision of the #EUPharma legislation and the opportunity to improve #AccessToMedicines for #CancerPatients : bit.ly/3T2eUHX

Director Yannis Natsis joins today #JarubasEUpharmaceuticalRoundtable

📢 #HealthcarePayers call to rebalance the #EUpharma ecosystem: priority is #Affordability & #StrongEvidence for effective treatment

Find more in our position💊
bit.ly/40uQ8lW

It's time to secure medicine supplies for patients! Join us at the #EUPharma roundtable, organised by the EPP Group at the European Parliament

We will discuss #incentives , AMR, Transferable vouchers, #Bolar , how the EU can deliver equitable #AccessForAll & the need for #CriticalMedsAct

Attending The Consumer Voice event hosted by Tiemo Wölken 🇪🇺 on #EUPharma , timely ahead of the #EUPharma Revision tomorrow

Director Yannis Natsis: high #prices are an escalator phenomenon. We need to rebalance the system to support affordable #access

#Affordability #StrongEvidence